<code id='E4DE06E896'></code><style id='E4DE06E896'></style>
    • <acronym id='E4DE06E896'></acronym>
      <center id='E4DE06E896'><center id='E4DE06E896'><tfoot id='E4DE06E896'></tfoot></center><abbr id='E4DE06E896'><dir id='E4DE06E896'><tfoot id='E4DE06E896'></tfoot><noframes id='E4DE06E896'>

    • <optgroup id='E4DE06E896'><strike id='E4DE06E896'><sup id='E4DE06E896'></sup></strike><code id='E4DE06E896'></code></optgroup>
        1. <b id='E4DE06E896'><label id='E4DE06E896'><select id='E4DE06E896'><dt id='E4DE06E896'><span id='E4DE06E896'></span></dt></select></label></b><u id='E4DE06E896'></u>
          <i id='E4DE06E896'><strike id='E4DE06E896'><tt id='E4DE06E896'><pre id='E4DE06E896'></pre></tt></strike></i>

          leisure time

          leisure time

          author:leisure time    Page View:7921
          Priscilla Chan, left, with Shana Kelley and Gov. J.B. Pritzker of Illinois at the new CZ Biohub Chicago. Courtesy Dale Ramos/Chan Zuckerberg Initiative

          CHICAGO — At what point does inflammation, a key component of the body’s immune defense system, swerve out of control and start to drive disease?

          That’s the key question that a new research center, the Chan Zuckerberg Biohub Chicago, has been created to try to answer.

          advertisement

          The Chicago hub is the second one started by the Chan Zuckerberg Initiative, the philanthropic organization of Facebook founder Mark Zuckerberg and his wife, Priscilla Chan. The first hub, based in the Bay Area, has been investigating cell biology and infectious diseases, while this new one is homing in on inflammatory processes in tissues across the body.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more
          Will generative AI in health care meet the fate of IBM's Dr. Watson?
          Will generative AI in health care meet the fate of IBM's Dr. Watson?

          MikeReddyforSTATThehealthcaresectorisanotoriouslaggardwhenitcomestotechnology.Itwasslowtousecomputer

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

          ThisistheinauguraleditionofAdam’sBiotechScorecard,anewsubscriber-onlynewsletter.STAT+subscriberscans